about
Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversionsDifferences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms.Overall and cause-specific mortality in HIV-positive subjects compared to the general population.Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis.Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy.Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain.Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort.All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.[The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up].Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic InfectionsHBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain[Present situation and future perspectives of the epidemic of HIV and AIDS in Spain]
P50
Q28542942-7A56FB3B-7234-4BC5-80A8-2A3B1056A377Q34192156-16A313DC-0B21-4436-8A6F-B42D760346CEQ34477113-7E823D24-9806-4E44-A524-4F201C5C49A4Q35370502-E91BFFDF-99F4-4159-BA13-C1C2E8B978BCQ36505229-5F0BC4EF-4A67-45D3-BCD9-975A20C9FE7EQ41663888-3AE65C2B-439F-4E9D-9A00-E1A8DBDE4F37Q41680569-D05C3978-F2CE-4CD0-8B8B-5CA7AD6BEF03Q42248751-E86643F7-6EC0-46A9-B9A3-55D2E4148F72Q47918470-53D0AFAC-3ACF-427C-91B7-445D316F238FQ50528350-55791259-D14D-47CC-97F4-27067E9DEBA1Q57982017-9B32284A-8FFE-422F-AF04-42D612503FBEQ59771046-F0262C0B-38D3-46CD-ACE5-895ECB84F56FQ61908255-6D331472-5AAF-4E15-8B1B-A8D05FE8EF2B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paz Sobrino-Vegas
@ast
Paz Sobrino-Vegas
@en
Paz Sobrino-Vegas
@es
Paz Sobrino-Vegas
@nl
Paz Sobrino-Vegas
@sl
type
label
Paz Sobrino-Vegas
@ast
Paz Sobrino-Vegas
@en
Paz Sobrino-Vegas
@es
Paz Sobrino-Vegas
@nl
Paz Sobrino-Vegas
@sl
prefLabel
Paz Sobrino-Vegas
@ast
Paz Sobrino-Vegas
@en
Paz Sobrino-Vegas
@es
Paz Sobrino-Vegas
@nl
Paz Sobrino-Vegas
@sl
P106
P31
P496
0000-0002-0775-1558